Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 4.86 MB
Add to list
  1. Search results
  2. Antibacterial and β-lactamase inhibit...

Antibacterial and β-lactamase inhibitory activity of monocyclic β-lactams

Lena Decuyper, Marko Jukič, Izidor Sosič, Aleš Žula, Matthias D'hooghe (UGent) and Stanislav Gobec
(2018) MEDICINAL RESEARCH REVIEWS. 38(2). p.426-503
Author
Organization
Keywords
antibacterial drug design, beta-lactamase, monobactams, monocyclic beta-lactams, siderophore, IN-VITRO ACTIVITY, SIDEROPHORE MONOSULFACTAM BAL30072, RESISTANT STAPHYLOCOCCUS-AUREUS, HUMAN-LEUKOCYTE ELASTASE, GRAM-NEGATIVE PATHOGENS, STRUCTURE-BASED DESIGN, SOLID-PHASE SYNTHESIS, BINDING PROTEIN 2A, SIDE-CHAIN SAR, INVITRO ACTIVITY

Downloads

  • Download
    (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 4.86 MB

Citation

Please use this url to cite or link to this publication:

MLA
Decuyper, Lena, et al. “Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.” MEDICINAL RESEARCH REVIEWS, vol. 38, no. 2, 2018, pp. 426–503, doi:10.1002/med.21443.
APA
Decuyper, L., Jukič, M., Sosič, I., Žula, A., D’hooghe, M., & Gobec, S. (2018). Antibacterial and β-lactamase inhibitory activity of monocyclic β-lactams. MEDICINAL RESEARCH REVIEWS, 38(2), 426–503. https://doi.org/10.1002/med.21443
Chicago author-date
Decuyper, Lena, Marko Jukič, Izidor Sosič, Aleš Žula, Matthias D’hooghe, and Stanislav Gobec. 2018. “Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.” MEDICINAL RESEARCH REVIEWS 38 (2): 426–503. https://doi.org/10.1002/med.21443.
Chicago author-date (all authors)
Decuyper, Lena, Marko Jukič, Izidor Sosič, Aleš Žula, Matthias D’hooghe, and Stanislav Gobec. 2018. “Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.” MEDICINAL RESEARCH REVIEWS 38 (2): 426–503. doi:10.1002/med.21443.
Vancouver
1.
Decuyper L, Jukič M, Sosič I, Žula A, D’hooghe M, Gobec S. Antibacterial and β-lactamase inhibitory activity of monocyclic β-lactams. MEDICINAL RESEARCH REVIEWS. 2018;38(2):426–503.
IEEE
[1]
L. Decuyper, M. Jukič, I. Sosič, A. Žula, M. D’hooghe, and S. Gobec, “Antibacterial and β-lactamase inhibitory activity of monocyclic β-lactams,” MEDICINAL RESEARCH REVIEWS, vol. 38, no. 2, pp. 426–503, 2018.
@article{8549972,
  author       = {{Decuyper, Lena and Jukič, Marko and Sosič, Izidor and Žula, Aleš and D'hooghe, Matthias and Gobec, Stanislav}},
  issn         = {{0198-6325}},
  journal      = {{MEDICINAL RESEARCH REVIEWS}},
  keywords     = {{antibacterial drug design,beta-lactamase,monobactams,monocyclic beta-lactams,siderophore,IN-VITRO ACTIVITY,SIDEROPHORE MONOSULFACTAM BAL30072,RESISTANT STAPHYLOCOCCUS-AUREUS,HUMAN-LEUKOCYTE ELASTASE,GRAM-NEGATIVE PATHOGENS,STRUCTURE-BASED DESIGN,SOLID-PHASE SYNTHESIS,BINDING PROTEIN 2A,SIDE-CHAIN SAR,INVITRO ACTIVITY}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{426--503}},
  title        = {{Antibacterial and β-lactamase inhibitory activity of monocyclic β-lactams}},
  url          = {{http://doi.org/10.1002/med.21443}},
  volume       = {{38}},
  year         = {{2018}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: